Abstract:ID 93978 Poster Board 520 Altered dopamine signaling in the central nervous system (CNS) has been the subject of many studies, as it has become a fundamental feature of numerous CNS diseases and disorders, including Parkinson's disease (PD) and substance use disorder (SUD). The dopamine transporter (DAT) is the primary regulator of dopamine (DA) signaling in the central nervous system (CNS) and in the periphery. This member of the re-uptake-1 monoamine transporters (MATs) clears extracellular dopamine by transporting it into the cell for storage. Recent studies have shown that peripheral immune cells such as monocytes and macrophages express DAT and the norepinephrine transporter (NET), and that DAT regulates innate immune response. Alterations of DAT in the CNS impacts the expression of this protein in peripheral immune cells affecting immune regulation. Development of methodologies and tools that will facilitate our understanding of the mechanism underlying these observations can facilitate strategies to study DAT-associated disease and disorders in the periphery. Fluorescently labelled ligands (FLL) have proven useful as tools to study protein expression, localization, and distribution and downstream processes in distinct live cell systems, opening a venue to study endogenously expressed proteins. In this work, we set out to develop a high affinity and selective FLL for the detection of DAT in peripheral blood mononuclear cells (PBMCs) by flow cytometry. For our synthetic design, we identified two atypical DAT inhibitors, JJC8-087 and JJC8-089, as parent ligands. These compounds bind with high affinity to DAT and selectivity over SERT and NET. Fluorescent labelling of the parent ligand was based on previously reported structure-activity relationship studies. Binding affinities of all final compounds for rDAT, rSERT and rNET were obtained via radioligand binding assay in Sprague-Dawley rat brain tissue and hDAT-HEK293 cell membranes. PBMCs were isolated from whole blood via density media centrifugation and samples treated with either the FLL or a control antibody were analyzed via flow cytometry on a 5-laser Cytek Aurora Spectral Cytometer. Probes based on JJC8-087 demonstrated the highest DAT affinity and were selective with respect to SERT and NET. The lead DiSulfoCy5 FLL, GC04-38 (rDAT K i = 159 nM) was ~26-fold rDAT selective over rSERT ( K i = 4.2 mM) and >63-fold selective over rNET ( K i = >10 mM), in addition, a similar binding affinity for hDAT was obtained ( K i = 191 nM). GC04-38 was used to label DAT in both mouse and human peripheral blood mononuclear cells (PBMCs) and analyzed via flow cytometry revealing comparable results with a control DAT antibody, reducing the time of sample preparation from 165 minutes (antibody control) to 30 min (FLL). We validated the selective detection of DAT with PBMCs isolated from a DAT knockout mouse demonstrating high specificity of this FLL. Overall, our results suggest a robust use for this novel FLL probe to increase our understanding of CNS-peripheral DAT regulation mechanisms underlying health and disease. This research is funded by the National Institutes of Health (NIH) – National Institute on Drug Abuse (NIDA) - Intramural Research Program.

Antibodies to Dopamine: Radioimmunological Study of Specificity in Relation to Immunocytochemistry

Antibodies against gamma-aminobutyric acid: specificity studies and immunocytochemical results.

Antisera to gamma-aminobutyric acid. I. Production and characterization using a new model system.

Antisera to gamma-aminobutyric acid. II. Immunocytochemical application to the central nervous system.

Autoradiographic Study of Dopamine Transporter in Rat Models of Parkinson Disease With~(125) I-β-CIT

Morphology of neurons in the rat basal forebrain nuclei: comparison between NADPH-diaphorase histochemistry and immunohistochemistry of glutamic acid decarboxylase, choline acetyltransferase, somatostatin and parvalbumin

In vitro characterization of [125I]HY-3-24, a selective ligand for the dopamine D3 receptor

Study of Ion-Selective Microelectrode Sensitive to Neurotransmitter Dopamine

A comparison of neuropeptide immunocytochemistry in fluid-fixed and freeze-dried brains

Autoradiographic Study on Dopamine Transporter in Rat Model of Parkinson's Disease with ~(99M)tc-Trodat-1

Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides

Synthesis and biological evaluation of 18 F-labelled deuterated tropane derivatives as dopamine transporter probes

Subcellular localization of D2 receptors in the murine substantia nigra

Fluorescently Labelled Ligand Allow Detection of DAT in Human and Mouse Peripheral Blood Monocytes by Flow Cytometry

A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques

Synthesis and initial evaluation of radioiodine-labelled deuterated tropane derivatives targeting dopamine transporter

Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study

Comparison of soluble dopamine D2-receptors from three species

A novel fluorescently labelled ligand for the detection of DAT in immune cells by flow cytometry

Specificity Controls for Immunocytochemistry

In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease